These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10626149)

  • 21. Immunoglobulin D myeloma--problems with diagnosing and staging (own experience and literature review).
    Kuliszkiewicz-Janus M; Zimny A; Sokolska V; Saşiadek M; Kuliczkowski K
    Leuk Lymphoma; 2005 Jul; 46(7):1029-37. PubMed ID: 16019554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin D multiple myeloma.
    Lin TL; Shih LY; Dunn P; Wang PN; Wu JH; Kao MC
    Chang Gung Med J; 2000 Aug; 23(8):451-7. PubMed ID: 11039246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunodiagnosis of IgD multiple myeloma. A report of 17 cases.
    Chernokhvostova EV; Batalova TN; German GP; Andreyeva NE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(4):539-52. PubMed ID: 6170548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgD multiple myeloma with renal involvement: case report.
    Homan H; Ohtubo Y; Ito H; Azuma K; Yasumoto Y; Ohtuka H; Uomizu K; Yamashita W; Uemura S; Ohsaki K
    Jpn J Med; 1990; 29(2):212-5. PubMed ID: 2232370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and outcome of autologous transplantation in rare myelomas.
    Morris C; Drake M; Apperley J; Iacobelli S; van Biezen A; Bjorkstrand B; Goldschmidt H; Harousseau JL; Morgan G; de Witte T; Niederwieser D; Gahrton G;
    Haematologica; 2010 Dec; 95(12):2126-33. PubMed ID: 20971818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgD kappa myeloma: a new case.
    Amine B; Benbouazza K; Harzy T; Rahmouni R; Guedira N; Lazrak N; Hajjaj-Hassouni N
    Joint Bone Spine; 2004 Jul; 71(4):331-3. PubMed ID: 15288860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsecretory IgD (kappa) multiple myeloma. Report of a case and review of the literature.
    Kanoh T; Niwa Y
    Am J Clin Pathol; 1987 Oct; 88(4):516-9. PubMed ID: 3116837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IgD myeloma. Report of a case with unusual clinical and immunologic features.
    Valenzuela R; Govindarajan S; Tubbs R; Deodhar S; Bukowski R
    Am J Clin Pathol; 1979 Aug; 72(2):246-50. PubMed ID: 112852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [IgD-multiple myeloma. Review of 102 cases reported in the literature (author's transl)].
    Knolle J; Meyer KH
    Immun Infekt; 1975 Jul; 3(3):125-34. PubMed ID: 810409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary plasma cell leukemia (IgD-lambda) with hyperammonemia].
    Minauchi K; Fujie T; Matsubara N; Kasahara H; Ogura Y; Tamura M; Yamane Y; Tanaka M; Taneichi K
    Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):139-41. PubMed ID: 14968586
    [No Abstract]   [Full Text] [Related]  

  • 31. [IgD myeloma manifesting as acute renal insufficiency].
    Duvic C; Sarret D; De Revel T; Hérody M; Didelot F; Labaye J; Nédélec G
    Rev Med Interne; 2000 Sep; 21(9):799-803. PubMed ID: 11039177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgD multiple myeloma. A report of three cases.
    Martini R; Santini S; Bottari G
    Minerva Med; 1996 Mar; 87(3):109-12. PubMed ID: 8668286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case report of biclonal immunoglobulin D lambda/lambda multiple myeloma in patient with liver echinococcosis.
    Prce A; Dunđerović Ž; Mikulić I; Mikulić V; Ljubić K; Ćuk A; Bogut A; Petrović J; Volarić M; Čolak T; Raguž F
    Biochem Med (Zagreb); 2024 Jun; 34(2):020801. PubMed ID: 38665868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Light chain multiple myeloma: an evaluation of its biochemical investigations.
    Zahari Sham SY; C Thambiah S; Samsudin IN; Lim SM
    Malays J Pathol; 2017 Dec; 39(3):311-315. PubMed ID: 29279596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal disease in myeloma. Role of the tumor cell mass (author's transl)].
    San Miguel J; Batlle J; Alberca I; Moraleda JM; López Borrasca A
    Med Clin (Barc); 1981 Apr; 76(8):347-9. PubMed ID: 7253752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
    Bladé J; San Miguel JF; Alcalá A; Maldonado J; Sanz MA; García-Conde J; Moro MJ; Alonso C; Besalduch J; Zubizarreta A
    J Clin Oncol; 1993 Jun; 11(6):1165-71. PubMed ID: 8501503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IgD-lambda type multiple myeloma associated with IgG-kappa type benign monoclonal gammopathy].
    Shimada H; Nishinarita S; Kishigami Y; Hayama T; Sawada U; Horie T; Nakamura N; Kato M; Hirano M; Nakamura O
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Apr; 18(2):235-40. PubMed ID: 7553059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical spectrum of light chain myeloma. A study of 35 patients with special reference to the occurrence of amyloidosis.
    Stone MJ; Frendel EP
    Am J Med; 1975 May; 58(5):601-19. PubMed ID: 1130419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgD myeloma: immunology and ultrastructure.
    Ioachim NJ; McKenna PJ; Halperin I; Chung FJ
    Ann Clin Lab Sci; 1978; 8(3):209-18. PubMed ID: 418730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgD monoclonal gammopathy of undetermined significance.
    Kinoshita T; Nagai H; Murate T; Saito H; Fukatsu T; Hotta T
    Int J Hematol; 1997 Feb; 65(2):169-72. PubMed ID: 9071822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.